This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland
Key Sessions
Sophia Hober, PhD
Development of Protein Domains for Diagnostic and Therapeutic Use
KTH Royal Institute of Technology
Leo James, PhD
Targeted Degradation of Proteins and Pathogens by the Cytosolic Antibody Receptor TRIM21
MRC Laboratory of Molecular Biology
Maartje Huijbers, PhD
The Peculiar Features of IgG4 MuSK Antibodies and How They Can Be Used As Therapeutics
Leiden University Medical Center
Anna M. Wu, Ph.D.
Delivering Light and Heat Using Engineered Antibodies and Fragments: ImmunoPET and Radioimmunotherapy
Beckman Research of the City of Hope